A PHASE II, OPEN-LABEL, PROSPECTIVE STUDY (TAPER) TO ASSESS...

A PHASE II, OPEN-LABEL, PROSPECTIVE STUDY (TAPER) TO ASSESS THE ABILITY OF ELTROMBOPAG TO INDUCE SUSTAINED TREATMENT-FREE REMISSION IN ITP PATIENTS WITH INSUFFICIENT RESPONSE TO CORTICOSTEROIDS

Cooper, N., Ghanima, W., Haenig, J., Jha, J., Lee, J., Zaja, F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000567480.47134.f7
Date:
June, 2019
File:
PDF, 561 KB
2019
Conversion to is in progress
Conversion to is failed